Target Audience and Goal Statement
This activity is intended for dermatologists, plastic surgeons, primary care providers, and nurses who are involved in aesthetic
procedures.
The goal of this activity is to review the similarities and differences between the 2 botulinum neurotoxin type A products
approved for aesthetic use in the United States, and to develop aesthetic treatment plans incorporating these products that
are based on clinical data and best injection practices.
Upon completion of this activity, participants will be able to:
- Review the clinical efficacy data supporting botulinum neurotoxin type A products for aesthetic use
- Describe the similarities and potential differences between the 2 botulinum neurotoxin type A products that have been approved
by the US Food and Drug Administration for aesthetic treatment
- Design aesthetic neurotoxin treatment plans that minimize side effects and deliver optimal patient outcomes
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Author(s)
-
Michael A.C. Kane, MD
Associate Attending Surgeon, Manhattan Eye, Ear and Throat Hospital, New York, NY
Disclosures
Disclosure: Michael A.C. Kane, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan, Inc.; Medicis Pharmaceutical Corporation; sanofi-aventis; BioForm Medical
Inc; Revance Therapeutics; Merz Pharmaceuticals GmbH
Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Medicis Pharmaceutical Corporation; sanofi-aventis;
Revance Therapeutics
Received grants for clinical research from: Medicis Pharmaceutical Corporation; Coapt Systems; Revance Therapeutics
Owns stock, stock options, or bonds from: Allergan, Inc.; Medicis Pharmaceutical Corporation; Revance Therapeutics
Dr. Kane does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Kane does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
-
Gary D. Monheit MD
Associate Clinical Professor, Department of Dermatology, Department of Ophthalmology, University of Alabama at Birmingham;
Physician, Total Skin and Beauty Dermatology Center, Birmingham, Alabama
Disclosures
Disclosure: Gary D. Monheit, MD, has disclosed the following relevant financial relationships: Served as a consultant for:
Allergan, Inc.; Genzyme Corporation; Colbar LifeScience, Ltd.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.;
Ipsen; Medicis Pharmaceutical Corporation; Stiefel Laboratories, Inc.; Electro-Optical Sciences, Inc.; Revance Therapeutics;
Galderma Laboratories, L.P.; Mentor Corporation; Merz Pharmaceuticals GmbH
Served as a clinical investigator for: Allergan, Inc.; Dermik Laboratories; Genzyme Corporation; Colbar LifeScience, Ltd.;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Contura International A/S; Ipsen; Medicis Pharmaceutical
Corporation; Electro-Optical Sciences, Inc.; Revance Therapeutics; Kythera Biopharmaceuticals; Galderma Laboratories, L.P.;
Mentor Corporation; Merz Pharmaceuticals GmbH
Dr. Monheit does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Monheit does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
-
Oscar Hevia, MD
Oscar Hevia, MD, Volunteer Associate Professor, Department of Dermatology, University of Miami School of Medicine, Miami,
Florida
Disclosures
Disclosure: Oscar Hevia, MD, has disclosed no relevant financial relationships.
Dr. Hevia does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Hevia does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Editor(s)
CME Reviewer/Nurse Planner
-
Laurie E. Scudder, DNP, NP
Accreditation Coordinator, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School
of Nursing and Allied Health, George Washington University, Washington, DC; Nurse Practitioner, School-Based Health Centers,
Baltimore City Public Schools, Baltimore, Maryland
Disclosures
Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.
Accreditation Statements
For Physicians
-
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.75
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Contact This Provider
For Nurses
-
Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission
on Accreditation.
Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. MedscapeCME encourages you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
